Our Pennsylvania Uloric lawsuit attorneys are here to help you if you or a loved one suffered serious personal injury or wrongful death while taking the prescription drug, Uloric. In a recent February 2019 safety announcement, the U.S. Federal Drug Administration (FDA) has strongly indicated an increased risk of heart related wrongful deaths in patients prescribed Uloric. Uloric, also known as febuxostat, is manufactured by Takeda Pharmaceuticals. Uloric was first introduced to the market in 2009, as an alternative to another gout medication, allopurinol, for the management of hyperuricemia. Concerned about Uloric causing cardiovascular conditions, the U.S.  Federal Drug Administration (FDA) stipulated that Takeda Pharmaceuticals conduct post-clinical trials for a 7-year period, for possible serious side effects. Please call an experienced Pennsylvania Uloric lawyer anytime for a free consultation.

Serious Uloric side effects include the following personal injuries: increased risk of cardiovascular death, liver damage, Uloric kidney damage and strokes. In addition, Uloric is also linked to rhabdomyolysis, bone marrow failure, autoimmune disorders, and Stevens Johnson Syndrome. Uloric is known to cause chest pain, shortness of breath, severe skin and allergic reactions, sudden severe headaches, gout flares, numbness or weakness on one side of your body, dizziness and rapid or irregular heartbeats. Additional side effects include Uloric pulmonary embolism (PE) and deep vein thrombosis (DVT). The U.S. Federal Drug Administration (FDA) is urging patients to immediately report these side effects to their health care professional. Call our Pennsylvania Uloric attorneys anytime for a free consultation and more free information regarding a possible Uloric class action lawsuit settlement.

Hyperuricemia is an excess of uric acid in the blood, in patients suffering from gout. There are reportedly over 8 million Americans who suffer from gout in the U.S.  Gout is a complex form of an inflammatory arthritic condition where an individual develops abnormally elevated levels of uric acid buildup. Uric acid is a breakdown product of purines, which are part of the many foods we eat. The tendency to develop gout can also be promoted by genetics, obesity, alcohol intake, high blood pressure, certain medications and decreased chronic kidney function. Normally, uric acid is removed through urination. In individuals with hyperuricemia, uric acid buildup generates a formation of razor sharp crystals in the joints, body fluids and tissues. This buildup causes escalating joint damage which is accompanied by intense pain, extreme discomfort, limited range of motion, redness and joint effusion, particularly in the big toe. Our gout uloric lawyers can help get you the gout medical treatment you need.

Uloric is meant to lower uric acid levels in the blood. Uloric was first approved in 2009. Uloric is xanathine oxidase inhibitor prescribed to treat a medical condition known as hyperuricemia in adult patients with gout. Inhibition of xanthine oxidase reduces the production of uric acid. This mechanism assists in preventing a buildup of urate crystals which triggers gout. Our Pennsylvania personal injury lawyers can help assist you with a Uloric lawsuit for injury and lawsuit settlement compensation.

Initial Uloric clinical studies exposed an increased risk serious personal injury of cardiac incidences in patients taking Uloric. Because of these pre-market clinical trials results, the Federal Drug Administration (FDA) stipulated that a 7-year post-clinical trial be conducted. In addition, the Federal Drug Administration (FDA) mandated the drug manufacturer, Takeda Pharmaceuticals to place warning labels and precautions in Uloric’s prescribing information. We are here to help you file a Pennsylvania Uloric lawsuit.

Takeda Pharmaceuticals complied with the Federal Drug Administration (FDA). These clinical trials increased concerns about the risk of taking Uloric and increased Pennsylvania wrongful deaths from heart-related causes. Our Uloric class action lawyers offer free consultations and we do not get paid until you and your family receive an Uloric lawsuit jury verdict or personal injury lawsuit settlement.

In a recent February 2019 safety announcement, Federal Drug Administration (FDA) has announced that there is an increased risk of death in patients prescribed Uloric.  Throughout the post clinical trials, the Federal Drug Administration (FDA) determined that Takeda Pharmaceuticals were substandard in reporting the risk of heart-related death. The Federal Drug Administration (FDA) is requiring Takeda Pharmaceuticals to package labels with a more prominent Black Box warning in addition to a new patient medication guide. A FDA Black Box warning is the most severe warning that can be issued. The Federal Drug Administration (FDA) also has limited the approval of Uloric. It suggests physicians prescribe Uloric only in patients who do not tolerate Zyloprim (allopurinol), an alternative gout medication. The Federal Drug Administration (FDA) is advising physicians to counsel their gout patients about the cardiovascular risk when taking Uloric. The Federal Drug Administration (FDA) is also urging patients and physicians to report these side effects to the Federal Drug Administration (FDA) MedWatch program. Call our Pennsylvania Uloric injury attorney anytime for a free consultation.

Takeda Pharmaceuticals is facing several Qui tam lawsuits. A former employee whistleblower claims Takeda Pharmaceuticals hid the risk information about Uloric, including cardiovascular death, liver problems, kidney failure and bone marrow failure. Claiming Takeda Pharmaceuticals knew of the risks associated with taking Uloric, the company failed to inform the public. Despite Takeda Pharmaceuticals awareness and strong medical data that Uloric causes serious injury and Pennsylvania wrongful death many patients continue to suffer from these health issues. If you or a loved one has suffered from the serious side effects or wrongful death call our Pennsylvania Uloric lawsuit lawyers anytime for a free consultation.

Our Pennsylvania personal injury lawyers work on a contingency fee, meaning we don’t get paid unless we secure financial compensation or lawsuit settlement for our injured clients. Additionally, all Uloric consultations are completely free so please give us a call to discuss a possible Uloric recall lawsuit. The top Uloric lawsuit lawyers will have a track record of lawsuit settlement success and high moral character in their local Commonwealth of Pennsylvania community. Our Allentown personal injury lawyers here to help get you and your family the justice and compensation they deserve.

Our Allentown Uloric lawsuit lawyers are happy to meet you in your home or local Pennsylvania hospital, if that is more convenient. If you are located in any of the following cities our attorneys can meet you at a moment’s notice: Allentown PA, Altoona PA, Bethlehem PA, Easton PA, Erie PA, Harrisburg PA, Hershey PA, Lancaster PA, Lehigh Valley PA, Philadelphia PA, Pocono PA, Reading PA, Scranton PA, State College PA, Stroudsburg PA, Wilkes-Barre PA, York PA or Phillipsburg NJ. Call us today for a free Uloric class action settlement consultation.

Call the Pennsylvania medical malpractice attorneys at the Trapani Law Firm today to set up your free consultation: (610) 351 – 2330. Our PA Uloric attorney consultations are completely free and our Defective Drug personal injury lawyers are happy to meet you or a loved one at your home or local Lehigh Valley hospital room. We’re here to help you and your family get back on their feet after surfing from a Uloric prescription.